Therapies for peripheral joint disease in psoriatic
This report provides elemental information and data relating to the clinical trials on Psoriatic
July 24, 2015 /PRNewswire-USNewswire/ -- For the first time, people with psoriasis and psoriatic
arthritis can contribute directly to the future of research into these chronic, systemic autoimmune diseases through the National Psoriasis Foundation's (NPF) patient-centered research network called Citizen Pscientist.
WAIKOLOA, HAWAII - Joint pain arising in a patient with psoriasis is by no means necessarily due to psoriatic
ST ALBANS, England, July 15, 2010 /PRNewswire/ -- The Psoriasis and Psoriatic
Arthritis Alliance (PAPAA) has launched a new secure eCommerce site http://www.
arthritis (PsA) is classified as a spondyloarthropathy and characterized by synovitis, enthesitis, dactylitis, and spondylitis, usually manifesting in a person with skin and nail psoriasis.
BOUDRY, Switzerland -- Celgene International Sarl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented the results from PALACE-1, the Company's first Phase III study in psoriatic
arthritis, at the American College of Rheumatology annual meeting in Washington, D.
July 15, 2015 /PRNewswire-USNewswire/ -- To increase the number of people with psoriatic
disease who are effectively treating their condition and improve their quality of life, the National Psoriasis Foundation and pharmaceutical company Pfizer will award up to $1 million in learning and change grants through a new grant program.
GOTHENBURG, SWEDEN -- In patients with both plaque psoriasis and psoriatic
arthritis, initial treatment with etanercept at 50 mg twice weekly resulted in faster clearance of skin lesions than 50 mg once weekly.
Data signalling that Enbrel(R) (etanercept) can improve the quality of life for people with psoriasis and psoriatic
arthritis were presented at the 18th Congress of the European Academy of Dermatology and Venereology (EADV), as Enbrel(R) (etanercept) reached its five-year anniversary since its approval in Europe as a treatment for psoriasis.
Through collaborative research of international working groups, classification criteria for psoriatic
arthritis (PsA) and ankylosing spondylitis (AS) have been developed or are being refined to aid characterization and diagnosis of SpAs and aid in research.
) has announced the addition of the "Global Psoriatic
Arthritis Epidemiology and Patient Flow Analysis - 2012" report to their offering.